Document:

Filed by Bowne Pure Compliance

 

Exhibit 10.65

SYNTROLEUM CORPORATION

2005 STOCK INCENTIVE PLAN

EMPLOYEE RESTRICTED STOCK AWARD AGREEMENT

THIS AGREEMENT (“Agreement”), made as of the 19th day of March 2007 (the “Grant Date”),
evidences an award by Syntroleum Corporation, a Delaware corporation (the “Company”) to John B.
Holmes, Jr. (the “Grantee”) pursuant to the 2005 Stock Incentive Plan (the “Plan”). Capitalized
terms used and not otherwise defined herein shall have the meaning ascribed thereto in the Plan.

1) Grant of Restricted Stock Award. Effective as of the Grant Date, pursuant to
Section 8 of the Plan, the Company has awarded to the Grantee a Restricted Stock Award with respect
to two-hundred thousand (200,000) shares of Common Stock, subject to the conditions and
restrictions set forth below and in the Plan (the “Restricted Stock”).

2) Restrictions. The Restricted Stock granted hereunder to the Grantee may not be
sold, assigned, transferred, pledged or otherwise encumbered from the Grant Date until the date
that the Grantee obtains a vested right to the shares (and the restrictions thereon terminate) in
accordance with the provisions of this Section 2. Provided that the Grantee has been in continuous
service as an employee since the Grant Date as of the date the relevant portion of the Restricted
Shares are scheduled to vest, the Grantee shall have a vested right to a number of shares, as
described below, out of the Restricted Stock grant described in Section 1, above, upon the
completion of each of the following events, as determined by the Committee in its discretion:

a.) 100,000 of such shares to vest upon execution of a definitive agreement with Tyson
Foods, Inc. or one of its subsidiaries and

b.) 100,000 of such shares to vest upon execution of a definitive agreement with China
Petroleum & Chemical Corporation or one of its subsidiaries (“Sinopec”); and

Notwithstanding the foregoing:

	 	a.	 	Grantee shall have a vested right to all of the Restricted Stock upon a
termination of Grantee’s service as an employee due to death or disability as a result
of injury or illness in the course and scope of his employment with the Company; and

	 	b.	 	Grantee shall have a vested right to all of the Restricted Stock upon a
Change in Control; and

	 	c.	 	Grantee shall have a vested right to all of the Restricted Stock upon a
termination of Grantee’s service as an employee by Grantee for Good Reason.

 

 

 

“Good Reason” shall be defined as:

(a) the assignment to the Grantee of any duties materially inconsistent in any
respect with the Grantee’s position (including status, offices, titles and
reporting requirements), authority, duties or responsibilities as contemplated by
Paragraph 1 of his Employment Agreement (“the Employment Agreement”), or any other
action by the Company which results in a diminution in such position, authority,
duties or responsibilities, excluding for this purpose an isolated, insubstantial
and inadvertent action not taken in bad faith and which is remedied by the Company
promptly after receipt of notice thereof given by the Grantee;

(b) any material failure by the Company to comply with any of the provisions
of the Employment Agreement, other than an isolated, insubstantial and inadvertent
failure not occurring in bad faith and which is remedied by the Company promptly
after receipt of notice thereof given by the Grantee;

(c) the Company’s requiring the Grantee to be based at any office outside the
Tulsa metropolitan area;

(d) any purported termination by the Company of the Grantee’s employment
otherwise than as expressly permitted by the Employment Agreement; or

(e) any failure to reelect Employee as a member of the Board of Directors of
the Company.

To the extent any of the shares of Restricted Stock have not vested as of March 16, 2017, such
unvested shares shall be forfeited.

The period of time between the Grant Date and the date that the Grantee obtains a vested right to
the Restricted Stock shall be referred to herein as the “Restricted Period” as to those shares. In
the event that any day on which the Grantee would otherwise obtain a vested right to the Restricted
Stock is a Saturday, Sunday or holiday, the Grantee shall instead obtain that vested right on the
first business day immediately following such date. Authorized leaves of absence from the Company
shall not constitute a termination of employment for purposes of this Agreement. For purposes of
this Agreement, an authorized leave of absence shall be an absence while Grantee is on military
leave, sick leave, or other bona fide leave of absence so long as Grantee’s right to employment
with the Company is guaranteed by statute, contract, or company policy. Whether the Grantee’s
employment terminates due to “disability” or “retirement” for purposes of this Agreement will be
determined by the Nominating and Compensation Committee of the Company’s Board of Directors (the
“Committee”) in its discretion.

3) Forfeiture. If Grantee’s employment terminates under circumstances other than those
provided in Section 2 prior to all or a portion of the Restricted Stock having become vested
pursuant to the provisions of Section 2, the Grantee shall forfeit all right to the Restricted Stock which has not yet vested as of the date of termination of employment.
Such forfeiture shall apply to Beneficiaries (as defined below) as well as the Grantee.

 

 

 

4) Share Issuance. The Company will issue to Grantee stock certificates evidencing the
shares of Restricted Stock, which certificates will be registered in the name of Grantee and will
bear an appropriate legend referring to the terms, conditions, and restrictions applicable to the
Restricted Stock, substantially in the following form:

The transferability of this certificate and the shares of Common
Stock represented hereby are subject to the terms, conditions and
restrictions (including forfeiture) contained in the Employee
Restricted Stock Award Agreement, effective as of March
19th, 2007, between Syntroleum Corporation and the
registered owner hereof. Copies of such Agreement are on file in
the offices of Syntroleum Corporation, 4322 South 49th West
Avenue, Tulsa, Oklahoma, 74107

The certificates evidencing the shares of Restricted Stock shall be held in custody by the Company
or, if specified by the Committee, by a third party custodian or trustee, until the restrictions on
such shares shall have lapsed, and, as a condition of this award of Restricted Stock, the Grantee
shall deliver a stock power, duly endorsed in blank, relating to the shares of Restricted Stock.
Upon the vesting and expiration of the restrictions as to any portion of the Restricted Stock, the
Company will cause a new certificate evidencing such number of shares of Common Stock to be
delivered to the Grantee, or in the case of his death to his Beneficiary, free of the legend
regarding transferability; provided that the Company shall not be obligated to issue any fractional
shares of Common Stock.

5) Beneficiary Designations. Pursuant to Section 10 of the Plan, the Grantee shall
file with the Company on such form as may be prescribed by the Company, a designation of one or
more beneficiaries and, if desired, one or more contingent beneficiaries (each referred to herein
as a “Beneficiary”) to whom shares of Common Stock otherwise due the Grantee under the terms of
this Agreement shall be distributed in the event of the death of the Grantee. The Grantee shall
have the right to change the Beneficiary or Beneficiaries from time to time; provided, however,
that any change shall not become effective until received in the Grantee’s handwriting by the
Committee. If there is no effective Beneficiary designation on file at the time of the Grantee’s
death, or if the designated Beneficiary or Beneficiaries have all predeceased such Grantee, the
payment of any remaining benefits under this Agreement shall be made to the personal representative
or executor of the Grantee’s estate. If one or more but not all the Beneficiaries have predeceased
such Grantee, the benefits under this Agreement shall be paid according to the Grantee’s
instructions in his designation of Beneficiaries. If the Grantee has not given instructions, or if
the instructions are not clear, the benefits under this Agreement which would have been paid to the
deceased Beneficiary or Beneficiaries will be paid to the personal representative or executor of
Grantee’s estate.

 

 

 

6) Nonalienation of Benefits. Except as contemplated by Section 5 above, no right or
benefit under this Agreement shall be subject to transfer, anticipation, alienation, sale,
assignment, pledge, encumbrance or charge, whether voluntary, involuntary or by operation of law,
and any attempt to transfer, anticipate, alienate, sell, assign, pledge, encumber or charge the
same shall be void. No right or benefit hereunder shall in any manner be liable for or subject to
any debts, contracts, liabilities or torts of the person entitled to such benefits. If the Grantee
or the Grantee’s Beneficiary hereunder shall become bankrupt or attempt to transfer, anticipate,
alienate, assign, sell, pledge, encumber or charge any right or benefit hereunder, other than as
contemplated by Section 5 above, or if any creditor shall attempt to subject the same to a writ of
garnishment, attachment, execution, sequestration or any other form of process or involuntary lien
or seizure, then such right or benefit shall cease and terminate.

7) Prerequisites to Benefits. Neither the Grantee, nor any person claiming through the
Grantee, shall have any right or interest in Restricted Stock awarded hereunder, unless and until
all the terms, conditions and provisions of this Agreement and the Plan which affect the Grantee or
such other person shall have been complied with as specified herein.

8) Issuance and Delivery of Shares. The Company shall not be obligated to issue or
deliver any shares of Common Stock if counsel to the Company determines that such issuance or
delivery would violate any applicable law or any rule or regulation of any governmental authority
or any rule or regulation of, or agreement of the Company with, any securities exchange or
association upon which the Common Stock is listed or quoted. If necessary to comply with any such
law, rule, regulation or agreement, the Company shall in no event be obligated to take any
affirmative action in order to cause the issuance or delivery of shares of Common Stock.

9) Rights as a Stockholder. During the period in which the restrictions provided
herein are applicable to the Restricted Stock, the Grantee shall have the right to vote the shares
of Restricted Stock and to receive any cash dividends paid with respect thereto unless and until
forfeiture thereof. Any dividend or distribution payable with respect to shares of Restricted
Stock that shall be paid or distributed in shares of Common Stock shall be subject to the same
restrictions provided for herein, and the shares so paid or distributed shall be deemed Restricted
Stock subject to all terms and conditions herein. Any dividend or distribution (other than cash or
Common Stock) payable or distributable on shares of Restricted Stock, unless otherwise determined
by the Committee, shall be subject to the terms and conditions of this Agreement to the same extent
and in the same manner as the Restricted Stock is subject; provided that the Committee may make
such modifications and additions to the terms and conditions (including restrictions on transfer
and the conditions to the timing and degree of lapse of such restrictions) that shall become
applicable to such dividend or distribution as the Committee may provide in its absolute
discretion.

 

 

 

10) Taxes. The Company shall have the right to withhold an appropriate amount of cash
or number of shares of Common Stock, or combination thereof, for payment of taxes or other amounts
required by law or to take such action as may be
necessary in the opinion of the Company to satisfy all obligations for withholding of taxes.
Withholding may be satisfied by the transfer to the Company of shares of Common Stock theretofore
owned by the Grantee, subject to such terms and conditions as the Committee shall prescribe.

11) Adjustments. As provided in the Plan, certain adjustments may be made to the
Restricted Stock upon the occurrence of events or circumstances described in Section 19 of the
Plan.

12) Notice. Unless the Company notifies the Grantee in writing of a different
procedure, any notice or other communication to the Company with respect to this Agreement shall be
in writing and shall be delivered personally or by first class mail, postage prepaid to the
following address:

Syntroleum Corporation

c/o Corporate Secretary

4322 South 49th West Avenue

Tulsa, Oklahoma 74107

Any notice or other communication to the Grantee with respect to this Agreement shall be in writing
and shall be delivered personally, or shall be sent by first class mail, postage prepaid, to
Grantee’s address as listed in the records of the Company on the Grant Date, unless the Company has
received written notification from the Grantee of a change of address.

13) Amendment. Without the consent of the Grantee, this Agreement may be amended or
supplemented (i) to cure any ambiguity or to correct or supplement any provision herein which may
be defective or inconsistent with any other provision herein, or (ii) to add to the covenants and
agreements of the Company for the benefit of Grantee or to add to the rights of the Grantee or to
surrender any right or power reserved to or conferred upon the Company in this Agreement, subject,
however, to any required approval of the Company’s stockholders and, provided, in each case, that
such changes or corrections shall not adversely affect the rights of Grantee with respect to the
Award evidenced hereby without the Grantee’s consent, or (iii) to make such other changes as the
Company, upon advice of counsel, determines are necessary or advisable because of the adoption or
promulgation of, or change in or of the interpretation of, any law or governmental rule or
regulation, including any applicable federal or state securities laws.

14) Grantee Employment. Nothing contained in this Agreement, and no action of the
Company or the Committee with respect hereto, shall confer or be construed to confer on the Grantee
any right to continue as an employee of the Company.

15) Governing Law. This Agreement shall be governed by, and construed in accordance
with, the internal laws of the State of Oklahoma.

16) Construction. References in this Agreement to “this Agreement” and the words
“herein,” “hereof,” “hereunder” and similar terms include the Plan. The headings of the Sections of
this Agreement have been included for convenience of reference only,
are not to be considered a part hereof and shall in no way modify or restrict any of the terms
or provisions hereof.

 

 

 

17) Relationship to the Plan. In addition to the terms and conditions described in
this Agreement, grants of Restricted Stock are subject to all other applicable provisions of the
Plan. The decisions of the Committee with respect to questions arising as to the interpretation of
the Plan, or this Agreement and as to finding of fact, shall be final, conclusive and binding.

	 	 	 	 	 
	 	 	SYNTROLEUM CORPORATION
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Richard L. Edmonson
	 

	 	 	 	 
	 

	 	Name:
	 	Richard. L. Edmonson
	 

	 	Title:
	 	Sr. Vice President and General Counsel
	 
	 	 	 	 
	 	 	GRANTEE
	 
	 	 	 	 
	 

	 	 	 	/s/ John B. Holmes, Jr.
	 

	 	 
	 

	 	John B. Holmes, Jr.Filed by Bowne Pure Compliance

 

Exhibit 10.66

Employment Agreement

CONFIDENTIAL

THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into on the 13th day of June,
2007 by and between Syntroleum Corporation, a Delaware corporation (the “Company”), and Ms. Karen
L. Gallagher, an individual (the “Employee”).

WHEREAS, the Company desires to enter into an employment relationship with Employee and
Employee is willing to accept such employment on the terms and conditions set forth herein.

NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter contained,
the Company and Employee hereby agree as follows.

1. Employment and Duties. The Company employs Employee in the capacity of Senior Vice
President and Principal Financial Officer, or in such other position as the Company may request of
the Employee. Employee’s initial duties and responsibilities are set forth in Exhibit A hereto.
Employee hereby accepts such employment, on the terms and conditions hereinafter set forth.
Employee agrees to perform such duties and responsibilities (including reasonable travel) and hold
such offices as may be reasonably assigned to Employee from time to time by the Company and to
devote substantially Employee’s full business time, energies and best efforts to the performance
thereof to the exclusion of all other business activities, except any activities disclosed to the
Company in advance and consented to by the Company. Company hereby consents to Employee
maintaining her part-time tax practice so long as said tax practice does not interfere with her
performing her duties and responsibilities to the Company and does not involve the Company in
controversy or adversely affect the Company’s reputation in the community and industry; such
determination to be at the sole discretion of the Company. Employee agrees to maintain her
certification as a certified public accountant. Employee shall be a member of the Company’s
executive committee and as such shall conduct herself with the highest standards of integrity and
professionalism, including those relating to maintenance of confidential information, duty to
inform her supervisor, and duty to report to the Company’s Audit Committee and Board of Directors.
Any changes to the Employee’s position with the Company, salary, incentive compensation or other
benefits shall not be valid unless in writing and executed by both the Company and Employee and
approved by the Board of Directors or appropriate committee of the Board of Directors.

2. Compensation. As compensation for the services to be rendered by Employee to the
Company pursuant to this Agreement, Employee shall be paid the following compensation and other
benefits.

(a) Salary in the amount of $175,000 per year, payable in equal bi-weekly installments in
arrears, or such higher compensation as may be established, but not guaranteed, by the Company from
time to time. Payments of salary shall be made in accordance with the Company’s usual payroll
procedures.

 

 

 

Syntroleum — Employment Agreement

CONFIDENTIAL

(b) Employee shall be eligible to participate, to the extent Employee may be eligible, in any
group medical and hospitalization, retirement, life insurance or other employee benefit plans
which the Company may from time to time offer to its similarly situated employees. All group
insurance provided to Employee shall be in such form and provide such coverage as is provided to
other similarly situated employees of the Company.

(c) All compensation payments to Employee shall be made subject to normal deductions
therefrom, including federal and state social security and withholding taxes.

3. Expenses. The Company shall reimburse Employee for Employee’s actual out-of-pocket
expenses incurred in accordance with Company policy in carrying out Employee’s duties hereunder in
the conduct of the Company’s business, including reasonable costs of continuing education to
maintain Employee’s certification as a certified public accountant, which expenses shall be
limited to ordinary and necessary items and which shall be supported by vouchers, receipts or
similar documentation submitted in accordance with the Company’s expense reimburse policy and as
required by law.

4. Vacations and Leave. Employee shall be entitled to four (4) weeks paid vacation
per year which shall be administered in accordance with the Company’s policies in effect from time
to time.

5. Non-Disclosure of Confidential Information.

(a) Employee acknowledges that in and as a result of Employee’s employment by the Company,
Employee will be making use of, acquiring, and/or adding to the Company’s Trade Secret Information.
Except as required in the performance of Employee’s duties under this Agreement, Employee will not
use any Trade Secret Information of the Company for Employee’s own benefit or purposes, including
but not limited to Employee’s discussions with the Company concerning the terms and conditions of
Employee’s employment with the Company, or disclose to third parties, directly or indirectly, any
Trade Secret Information of the Company, either during or after Employee’s employment with the
Company.

(b) As used in this Agreement, “Trade Secret Information” means information, including any
areas of business focus for the Company, business strategy, research and development activities,
business plans, budgets, formula, pattern, compilation, program, device, method, technique or
process, that: (i) derives independent economic value, actual or potential, from not being
generally known to, and not being readily ascertainable by proper means by other persons who can
obtain economic value from its disclosure or use, and (ii) is the subject of efforts that are
reasonable under the circumstances to maintain its secrecy. For purposes of this Agreement, “Trade
Secret Information” includes both information disclosed to Employee by the Company and information
developed by Employee in the course of Employee’s employment with the Company. The types and
categories of information which the Company considers to be its Trade Secret Information include,
without limitation: (a) specifications, descriptions, designs, dimensions, content (including
chemical composition) and tolerances of products, parts and components; (b) plans, blueprints,
design packages, construction, part and assembly drawings and diagrams; (c)

 

2

 

Syntroleum — Employment Agreement

CONFIDENTIAL

design, construction and component costs and cost estimates; (d) the existence, terms or conditions
of any agreements (including license agreements) between the Company and any third party; (e)
computer programs (whether in the form of source code, object code or any other form, including
software, firmware and programmable array logic), formulas, algorithms, methods, techniques,
processes, designs, specifications, diagrams, flow charts, manuals, descriptions, instructions,
explanations, improvements, and the ideas, systems and methods of operation contained in such
programs; (f) information concerning or resulting from research and development work planned, in
progress, or performed by the Company; (g) information concerning the Company’s management, Board
of Directors, insurance status, human resources, financial condition, financial operations,
purchasing activities, sales activities, marketing activities and business plans; (h) information
acquired or compiled by the Company concerning actual or potential customers; and (i) all other
types and categories of information (in whatever form) with respect to which, under all the
circumstances, Employee knows or has reason to know that the Company intends or expects secrecy to
be maintained and as to which the Company has made efforts to maintain its secrecy.

(c) In the event that Employee is requested or required by applicable law or by deposition,
interrogatory, request for documents, subpoena, civil investigative demand or similar process to
disclose any of the Company’s Trade Secret Information, Employee shall provide the Company with
prompt written notice of such request or requirement prior to making the requested disclosure, and
shall cooperate with the Company so that the Company may seek to protect the proprietary nature of
such Trade Secret Information through available procedures, including a protective order or other
appropriate remedy.

(d) The Company may also advise Employee from time to time as to restrictions upon the use or
disclosure of specified information which has been licensed or otherwise disclosed to the Company
by third parties pursuant to license or confidential disclosure agreements which contain
restrictions upon the use or disclosure of such information. Employee agrees to abide by the
restrictions upon use and/or disclosure contained in such agreements.

(e) Employee has not and will not use or disclose to the Company any confidential or
proprietary information belonging to others without the written consent of the person to whom such
information is confidential, and Employee represents that Employee’s employment with the Company
will not require the use of such information or the violation of any confidential relationship with
any third party.

6. Other Property of the Company. All documents, encoded media, and other tangible
items provided to Employee by the Company or prepared, generated or created by Employee or others
in connection with any business activity of the Company are the property of the Company. Upon
termination of Employee’s employment with the Company, Employee will promptly deliver to the
Company all such documents, media and other items in Employee’s possession, including all complete
or partial copies, recordings, abstracts, notes or reproductions of any kind made from or about
such documents, media, items or information contained therein. Employee will neither have
nor claim any right, title or interest in any trademark, service mark or trade name owned or used
by the Company.

 

3

 

Syntroleum — Employment Agreement

CONFIDENTIAL

7. Inventions and Works of Authorship.

(a) Employee agrees to assign and hereby irrevocably assigns to the Company all of Employee’s
right, title and interest in and to any and all Inventions and Works of Authorship made, generated
or conceived by Employee during the period of Employee’s employment with the Company, and Employee
agrees to and shall promptly disclose all such Inventions and Works of Authorship to the Company in
writing. As used herein, “Invention” means any discovery, improvement, innovation, idea, formula,
or shop right (whether or not patentable, whether or not put into writing and whether or not put
into practice) made, generated or conceived by Employee (whether alone or with others) while
employed by the Company. For purposes of this Agreement, any discovery, improvement, innovation,
idea, formula, or shop right (whether or not patentable, whether or not put into writing and
whether or not put into practice) relating directly or indirectly to the business of the Company or
to the Company’s actual or demonstrably anticipated business, research or development with respect
to which Employee files a patent application within two years after termination of employment with
the Company shall be presumed to be an Invention. As used herein, “Work of Authorship” means any
original work of authorship within the purview of the copyright laws of the United States of
America, and both the Company and Employee intend and agree that all Works of Authorship created by
Employee in the course of his employment with the Company will be and shall constitute works made
for hire within the meaning and purview of such copyright laws.

(b) Employee will execute and assign any and all applications, assignments, and other
documents and will render all assistance which may be reasonably necessary for the Company to
obtain patent, copyright, or any other form of intellectual property protection with respect to all
Inventions and Works of Authorship in all countries and will cooperate with Syntroleum as
reasonable necessary to enforce any such intellectual property protection. The Company will pay
Employee $200 for each patent issued to the Company upon which Employee’s name appears as an
inventor.

(c) The provisions of this Section 7 do not apply to an invention for which no equipment,
supplies, facility or Trade Secret Information of the Company was used and which was developed
entirely on Employee’s own time, and which does not relate (i) directly or indirectly to the
business research or development of the Company, or (ii) to the Company’s actual or demonstrably
anticipated business, research or development. A reasonable determination of the applicability of
Section 7(a) to an Employee’s invention shall be made by Syntroleum after the Employee submits
notification in writing of the invention. Said notice shall include adequate detail for Syntroleum
to evaluate the invention. Said notice shall include adequate detail for Syntroleum to evaluate
the invention.

 

4

 

Syntroleum — Employment Agreement

CONFIDENTIAL

8. Limited Covenants.

(a) Non-Solicitation of Customers/Licensees — Employee further acknowledges that,
while employed by the Company, he will have contact with and become aware of the Company’s
customers and licensees and their respective representatives, including their names and addresses,
specific needs and requirements, as well as leads and references to prospective customers and
licensees. Employee further acknowledges that loss of such customers or licensees would cause the
Company great and irreparable harm. Employee agrees that for a period of one year following
termination of Employee’s employment with the Company for any reason, voluntarily or involuntarily,
Employee will not directly or indirectly solicit, contact, call upon, communicate with or attempt
to communicate with any customer or licensee, former customer or licensee, or prospective customer
or licensee of the Company known to the Employee for the purpose of selling, installing,
implementing, or modifying any Competing Product. This restriction shall apply to any customer or
licensee, former customer or licensee, or prospective customer or licensee of the Company, whether
Employee had direct contact or not.

(b) Non-Solicitation of Company Employees — The Employee agrees that for as long as
he is employed by the Company and for a period of one year after termination of Employee’s
employment with the Company for any reason, voluntarily or involuntarily, Employee will not
solicit, recruit, hire or attempt to solicit, recruit or hire, directly or by assisting others, any
other employee of the Company.

(c) “Competing Product” and “contact” defined. As used in this Agreement, (i) “Competing
Product” means any product (including, without limitation, any chemical formula or process) which
is or may be marketed in competition with any product marketed or under development by the Company
at any time, and (ii) “contact” means interaction between Employee and a customer or licensee,
former customer or licensee, or prospective customer or licensee of the Company, which takes place
to further any business relationship; or performing services for the customer or licensee, former
customer or licensee, or prospective customer or licensee.

9. Reasonableness of Restrictions.

(a) Employee expressly acknowledges that he has carefully read and considered the provisions
of Sections 5, 6, 7, and 8, and, having done so, agrees that the restrictions set forth in these
Sections, including, but not limited to, the time periods and geographic areas of restriction are
fair and reasonable and are reasonably required for the protection of the interests of the Company
and its officers, directors, shareholders and other employees.

(b) In the event that, notwithstanding the foregoing, any of the provisions of Sections 5, 6,
7, and 8 shall be held to be invalid or unenforceable, the remaining provisions thereof shall
nevertheless continue to be valid and enforceable as though the invalid or unenforceable parts had
not been included therein. In the event that any provision of Sections 5, 6, 7 and 8 relating to
the time period and/or the areas of restriction and/or related aspects shall be declared by a court
of competent jurisdiction to exceed the maximum restrictiveness such court deems reasonable and
enforceable, the time period and/or areas of restriction and/or related aspects deemed reasonable
and enforceable by the court shall become and thereafter be the maximum restriction in such regard,
and the restriction shall remain enforceable to the fullest extent deemed reasonable by such court.

 

5

 

Syntroleum — Employment Agreement

CONFIDENTIAL

10. Requests for Clarification. In the event Employee is uncertain as to the meaning
of any provision of this Agreement or its application to any particular information, item or
activity, Employee will inquire in writing to the Company, specifying any areas of uncertainty.
The Company will respond in writing within a reasonable time and will endeavor to clarify any areas
of uncertainty, including such things as whether it considers particular information to be its
Trade Secret Information or whether it considers any particular activity or employment to be in
violation of this Agreement.

11. Remedies. In the event of a breach or threatened breach of any of the covenants
in Sections 5, 6, 7 and 8, the Company shall have the right to seek monetary damages and equitable
relief, including specific performance by means of an injunction against Employee or against
Employee’s partners, agents, representatives, servants, employers, employees, family members and/or
any and all persons acting directly or indirectly by or with him, to prevent or restrain any such
breach.

12. Term and Termination.

(a) The term of this Agreement shall be until August 15, 2007. The period from execution of
this Agreement until August 15, 2007 shall constitute Employee’s Probationary Period.
Notwithstanding any other provision hereof, the Company may terminate this Agreement for any reason
on or before August 15, 2007 with no obligations to Employee pursuant to Sections 12(f) or 13.
Should this Agreement continue after the Probationary Period, this Agreement shall thereafter be
for a term of 12 months from the Agreement Effective Date hereof, unless sooner terminated as
provided herein, and shall thereafter be automatically renewed for successive terms of 12 months
each unless sooner terminated as provided herein.

(b) Employment of Employee under this Agreement may be terminated:

(i) by the Company upon the death of Employee.

(ii) by the Company if Employee becomes disabled. For the purposes of this Agreement,
Employee will be deemed disabled if he (i) has been declared legally incompetent by a final
court decree (the date of such decree being deemed to be the date on which the disability
occurred), or (ii) receives disability insurance benefits from any disability income
insurance policy maintained by the Company for a period of three consecutive months, or
(iii) has been found to be disabled pursuant to a disability determination. A “disability
determination” means a finding that Employee, because of a medically determinable disease,
injury, or other mental or physical disability, is unable to perform substantially all of
his regular duties to the Company and that such disability is

 

6

 

Syntroleum — Employment Agreement

CONFIDENTIAL

determined or reasonably expected to last at least six months. The disability determination
shall be based upon the written opinion of the physician regularly attending Employee whose
disability is in question. If the Company disagrees with the opinion of this physician (the
“First Physician”), it may engage, at its own expense, another physician of its choice (the
“Second Physician”) to examine Employee. If the First and Second Physicians agree in
writing that Employee is or is not disabled, their written opinion shall, except as
otherwise set forth in this subsection, be conclusive on the issue of disability. If the
First and Second Physicians disagree on the disability of Employee, they shall choose a
third consulting physician (whose expense shall be borne by the Company), and the written
opinion of a majority of these three physicians shall, except as otherwise provided in this
subsection, be conclusive as to Employee’s disability. The date of any written opinion
conclusively finding Employee to be disabled is the date on which the disability will be
deemed to have occurred. If there is a conclusive finding that Employee is not totally
disabled, the Company shall have the right to request additional disability determinations
provided it agrees to pay all the expenses of the disability determinations and does not
request an additional disability determination more frequently than once every three months.
In connection with any disability determination, Employee hereby consents to any required
medical examination, and agrees to furnish medical information requested by any examining
physician and to waive any applicable physician-patient privilege that may arise because of
such examination. All physicians except the First Physician must be board-certified in the
specialty most closely related to the nature of the disability alleged to exist.

(iii) under any retirement policy applicable to all executive officers adopted by the
Company.

(iv) by mutual agreement of Employee and the Company.

(v) by the Company upon the dissolution and liquidation of the Company (other than as
part of a reorganization, merger, consolidation or sale of all or substantially all of the
assets of the Company whereby the business of the Company is continued).

(vi) by the Company for just cause at any time upon written notice. For purposes of
this Agreement, “just cause” may include, but is not necessarily limited to, the following:
(A) Employee’s material breach of Employee’s obligations, duties and responsibilities under
any term or provision of this Agreement, which breach remains uncured for a period of five
days after written notice by the Company to Employee; (B) Employee’s failure to adhere to
the standards of performance and conduct prescribed by the Company, including but not
limited to those policies set forth in the Employee Policy Manual as it may exist from time
to time and as set forth in Section 1 hereof; (C) Employee’s act of insubordination to the
Company’s Board of Directors or senior management; (D) Employee’s gross negligence or
willful misconduct in the performance of his duties under this Agreement; (E) Employee’s
dishonesty, fraud, misappropriation, disruption of the workplace or embezzlement in the
course of, related to or connected with the business of the Company; (F) Employee’s
conviction of a felony; (G) Employee’s failure (after written notice to Employee of such
failure and Employee not correcting such failure within five days of such notice) to devote
Employee’s time, attention and best efforts to the business of the Company as provided in
this Agreement; or (H) Employee asserting claims or filing of litigation against the Company
which is determined to be frivolous. The determination of “just cause” under subsections
(A) through (H) shall be made at the sole discretion and decision of Syntroleum.

 

7

 

Syntroleum — Employment Agreement

CONFIDENTIAL

(vii) by either the Company or Employee for any reason upon 15 days written notice.

(c) Any termination of Employee’s employment, either by the Company or Employee, shall be
communicated by a written notice of termination to the other party. A notice of termination which
includes conditions to such notice of termination shall be considered a notice of termination
without such conditions.

(d) If Employee’s employment is terminated pursuant to the terms of this Agreement for any
reason, Employee shall be entitled to all arrearages of salary and expenses up to and including the
date of termination but shall not be entitled to further compensation except as expressly provided
in Sections 12(f) or 13 below.

(e) Upon termination of employment for any reason, Employee shall deliver all Trade Secret
Information of the Company to an authorized representative of the Company, and the non-disclosure
provisions of Section 5 shall survive such termination and shall remain in full force and
effect for a period of 15 years from such expiration or termination.

(f) Except as provided in Section 12(a), should this Agreement and hence Employee’s employment
be terminated by the Company pursuant to Section 12(b)(iii), (iv), (v) or (vii), Company will offer
Employee a severance equal to Employee’s monthly salary for three (3) months, less normal
deductions. Said amount shall be paid out over for three (3) months during normal biweekly pay
periods. This severance shall be offered to Employee in exchange for execution of a Separation and
Release Agreement. The Employee’s severance is not guaranteed by this Agreement. Should Employee
accept the terms and conditions of a Separation and Release Agreement releasing all claims against
the Company and its affiliates related to Employee’s employment or termination of employment
Employee shall receive Employee’s severance as set forth in this Section 12(f). If Employee does
not accept the terms of the Separation and Release Agreement within the time period specified
therein (which in no event shall be later than 45 days after the date such agreement is offered to
Employee will be entitled to nothing more than all arrearages of salary, accrued vacation time, and
expenses up to and including the date of termination. Any violation of this Agreement during the
period of notification provided for in Section 12(b)(vii) above which would qualify Employee for
termination for just cause shall constitute grounds for Company to withdraw the offer of payment of
severance hereunder.

 

8

 

Syntroleum — Employment Agreement

CONFIDENTIAL

13. Change of Control.

Except as provided in Section 12(a), in the event of a Change of Control of the Company and during
the one-year period immediately following any Change of Control, (i) the Company terminates
Employee’s employment for any reason other than Employee’s death, disability, or just cause as
provided in Sections 12(b)(i), (ii), and (vi), respectively, or (ii) the Employee terminates his
employment for Good Reason, Company will offer Employee a severance equal to his monthly salary for
three (3) months, less normal deductions. Said amount shall be paid out over for three (3) months
during normal biweekly pay periods. This severance shall be offered to Employee in exchange for
execution of a Separation and Release Agreement. The Employee’s severance is not guaranteed by
this Agreement, but shall be offered to him. Should he accept the terms and conditions of a
Separation and Release Agreement releasing all claims against the Company and its affiliates
related to his employment or termination of employment he shall receive his severance as set forth
in this Section 13. If he does not accept the terms of the Separation and Release Agreement within
the time period specified therein (which in no event shall be later than 45 days after the date
such agreement is offered to him), he will be entitled to nothing more than all arrearages of
salary, accrued vacation time, and expenses up to and including the date of termination.

(a) Anything in this Agreement to the contrary notwithstanding, if a Change of Control occurs
and if the Employee’s employment with the Company is terminated prior to the date on which the
Change of Control occurs, and if it is reasonably demonstrated by the Employee that such
termination of employment (i) was at the request of a third party who has taken steps reasonably
calculated to effect the Change of Control or (ii) otherwise arose in connection with or
anticipation of the Change of Control, then for all purposes of this Agreement, the “Change of
Control” shall be deemed to have occurred on the date immediately prior to the date of such
termination of employment.

(b) As used in this Agreement, the terms set forth below shall have the following respective
meanings:

(i) “Affiliate” shall have the meaning ascribed to such term in Rule 12b-2 of the General
Rules and Regulations under the Exchange Act, as in effect on the Agreement Effective Date.

(ii) “Agreement Effective Date” shall mean June 13, 2007 .

(iii) “Associate” shall mean, with reference to any Person, (a) any corporation, firm,
partnership, association, unincorporated organization or other entity (other than the Company or a
subsidiary of the Company) of which such Person is an officer or general partner (or officer or
general partner of a general partner) or is, directly or indirectly, the Beneficial Owner of 10% or
more of any class of equity securities, (b) any trust or other estate in which such Person has a
substantial beneficial interest or as to which such Person serves as trustee or in a similar
fiduciary capacity and (c) any relative or spouse of such Person, or any relative of such spouse,
who has the same home as such Person.

 

9

 

Syntroleum — Employment Agreement

CONFIDENTIAL

(iv) “Beneficial Owner” shall mean, with reference to any securities, any Person if:

(a) such Person or any of such Person’s Affiliates and Associates, directly or
indirectly, is the “beneficial owner” of (as determined pursuant to Rule 13d-3 of the
General Rules and Regulations under the Exchange Act, as in effect on the Agreement
Effective Date) such securities or otherwise has the right to vote or dispose of such
securities, including pursuant to any agreement, arrangement or understanding (whether or
not in writing); provided, however, that a Person shall not be deemed the “Beneficial Owner”
of, or to “beneficially own,” any security under this subsection (a) as a result of an
agreement, arrangement or understanding to vote such security if such agreement, arrangement
or understanding: (i) arises solely from a revocable proxy or consent given in response to a
public (i.e., not including a solicitation exempted by Rule 14a-2(b)(2) of the General Rules
and Regulations under the Exchange Act) proxy or consent solicitation made pursuant to, and
in accordance with, the applicable provisions of the General Rules and Regulations under the
Exchange Act and (ii) is not then reportable by such Person on Schedule 13D under the
Exchange Act (or any comparable or successor report);

(b) such Person or any of such Person’s Affiliates and Associates, directly or
indirectly, has the right or obligation to acquire such securities (whether such right or
obligation is exercisable or effective immediately or only after the passage of time or the
occurrence of an event) pursuant to any agreement, arrangement or understanding (whether or
not in writing) or upon the exercise of conversion rights, exchange rights, other rights,
warrants or options, or otherwise; provided, however, that a Person shall not be deemed the
Beneficial Owner of, or to “beneficially own,” (i) securities tendered pursuant to a tender
or exchange offer made by such Person or any of such Person’s Affiliates or Associates until
such tendered securities are accepted for purchase or exchange or (ii) securities issuable
upon exercise of Exempt Rights; or

(c) such Person or any of such Person’s Affiliates or Associates (i) has any agreement,
arrangement or understanding (whether or not in writing) with any other Person (or any
Affiliate or Associate thereof) that beneficially owns such securities for the purpose of
acquiring, holding, voting (except as set forth in the proviso to subsection (a) of this
definition) or disposing of such securities or (ii) is a member of a group (as that term is
used in Rule 13d-5(b) of the General Rules and Regulations under the Exchange Act) that
includes any other Person that beneficially owns such securities;

provided, however, that nothing in this definition shall cause a Person engaged in business as an
underwriter of securities to be the Beneficial Owner of, or to “beneficially own,” any securities
acquired through such Person’s participation in good faith in a firm commitment underwriting until
the expiration of 40 days after the date of such acquisition. For purposes hereof, “voting” a
security shall include voting, granting a proxy, consenting or making a request or demand relating
to corporate action (including, without limitation, a demand for a stockholder list, to call a
stockholder meeting or to inspect corporate books and records) or otherwise giving an authorization
(within the meaning of Section 14(a) of the Exchange Act) in respect of such security.

 

10

 

Syntroleum — Employment Agreement

CONFIDENTIAL

The terms “beneficially own” and “beneficially owning” shall have meanings that are
correlative to this definition of the term “Beneficial Owner.”

(v) “Change of Control” shall mean any of the following:

(a) any Person (other than an Exempt Person) or Group (other than a Group comprised
entirely of Exempt Persons) shall become the Beneficial Owner of 30% or more of the shares
of Common Stock then outstanding or 30% or more of the combined voting power of the Voting
Stock of the Company then outstanding; provided, however, that no Change of Control shall be
deemed to occur for purposes of this subsection (a) if such Person or Group shall become a
Beneficial Owner of 30% or more of the shares of Common Stock or 30% or more of the combined
voting power of the Voting Stock of the Company solely as a result of (i) an Exempt
Transaction or (ii) an acquisition by a Person or Group directly from the Company;

(b) individuals who, as of the Agreement Effective Date, constitute the Board (the
“Incumbent Board”) cease for any reason to constitute at least a majority of the Board;
provided, however, that any individual becoming a director subsequent to the Agreement
Effective Date whose election, or nomination for election by the Company’s shareholders, was
approved by a vote of at least a majority of the directors then comprising the Incumbent
Board shall be considered as though such individual were a member of the Incumbent Board;
provided, further, that there shall be excluded, for this purpose, any such individual whose
initial assumption of office occurs as a result of any actual or threatened election contest
that is subject to the provisions of Rule 14a-11 under the Exchange Act;

(c) approval by the shareholders of the Company of a reorganization, merger or
consolidation, in each case, unless, following such reorganization, merger or consolidation,
(i) more than 50% of the then outstanding shares of common stock of the corporation
resulting from such reorganization, merger or consolidation and the combined voting power of
the then outstanding Voting Stock of such corporation is then beneficially owned, directly
or indirectly, by all or substantially all of the Persons who were the Beneficial Owners of
the outstanding Common Stock immediately prior to such reorganization, merger or
consolidation in substantially the same proportions as their ownership, immediately prior to
such reorganization, merger or consolidation, of the outstanding Common Stock and (ii) at
least a majority of the members of the board of directors of the corporation resulting from
such reorganization, merger or consolidation were members of the Incumbent Board at the time
of the execution of the initial agreement or initial action by the Board providing for such
reorganization, merger or consolidation; or

 

11

 

Syntroleum — Employment Agreement

CONFIDENTIAL

(d) approval by the shareholders of the Company of (i) a complete liquidation or
dissolution of the Company unless such liquidation or dissolution is approved as part of a
plan of liquidation and dissolution involving a sale or disposition of all or substantially
all of the assets of the Company to a subsidiary of the Company or a corporation with
respect to which, following such sale or other disposition, all of the requirements of
clauses (ii)(A)and (B) of this subsection (d) are satisfied, or (ii) the sale or other
disposition of all or substantially all of the assets of the Company, other than to a
subsidiary of the Company or a corporation, with respect to which, following such sale or
other disposition, (A) more than 50% of the then outstanding shares of common stock of such
corporation and the combined voting power of the Voting Stock of such corporation is then
beneficially owned, directly or indirectly, by all or substantially all of the Persons who
were the Beneficial Owners of the outstanding Common Stock immediately prior to such sale or
other disposition in substantially the same proportion as their ownership, immediately prior
to such sale or other disposition, of the outstanding Common Stock and (B) at least a
majority of the members of the board of directors of such corporation were members of the
Incumbent Board at the time of the execution of the initial agreement or initial action of
the Board providing for such sale or other disposition of assets of the Company.

(vi) “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.

(vii) “Exempt Person” shall mean the Company, any subsidiary of the Company, any employee
benefit plan of the Company or any subsidiary of the Company, and any Person organized, appointed
or established by the Company for or pursuant to the terms of any such plan.

(viii) “Exempt Rights” shall mean any rights to purchase shares of Common Stock or other
Voting Stock of the Company if at the time of the issuance thereof such rights are not separable
from such Common Stock or other Voting Stock (i.e., are not transferable otherwise than in
connection with a transfer of the underlying Common Stock or other Voting Stock) except upon the
occurrence of a contingency, whether such rights exist as of the Agreement Effective Date or are
thereafter issued by the Company as a dividend on shares of Common Stock or other Voting Securities
or otherwise.

(ix) “Exempt Transaction” shall mean an increase in the percentage of the outstanding shares
of Common Stock or the percentage of the combined voting power of the outstanding Voting Stock of
the Company beneficially owned by any Person solely as a result of a reduction in the number of
shares of Common Stock then outstanding due to the repurchase of Common Stock or Voting Stock by
the Company, unless and until such time as (a) such Person or any Affiliate or Associate of such
Person shall purchase or otherwise become the Beneficial Owner of additional shares of Common Stock
constituting 1% or more of the then outstanding shares of Common Stock or additional Voting Stock
representing 1% or more of the combined voting power of the then outstanding Voting Stock, or (b)
any other Person (or Persons) who is (or collectively are) the Beneficial Owner of shares of Common
Stock constituting 1% or more of the then outstanding shares of Common Stock or Voting Stock representing 1% or more of the combined
voting power of the then outstanding Voting Stock shall become an Affiliate or Associate of such
Person.

 

12

 

Syntroleum — Employment Agreement

CONFIDENTIAL

(x) “Good Reason” shall mean:

(a) the assignment to the Employee of any duties materially inconsistent in any
respect with the Employee’s position (including status, offices, titles and
reporting requirements), authority, duties or responsibilities as contemplated by
Section 1 of this Agreement, or any other action by the Company which results in a
diminution in such position, authority, duties or responsibilities, excluding for
this purpose an isolated, insubstantial and inadvertent action not taken in bad
faith and which is remedied by the Company promptly after receipt of notice thereof
given by the Employee;

(b) any material failure by the Company to comply with any of the provisions of
this Agreement, other than an isolated, insubstantial and inadvertent failure not
occurring in bad faith and which is remedied by the Company promptly after receipt
of notice thereof given by the Employee;

(c) the Company’s requiring the Employee to be based at any office outside the
Tulsa metropolitan area; or

(d) any purported termination by the Company of the Employee’s employment
otherwise than as expressly permitted by this Agreement.

(xi) “Group” shall mean any group within the meaning of Section 13(d)(3) or 14(d)(2) of the
Exchange Act.

(xii) “Person” shall mean any individual, firm, corporation, partnership, association, trust,
unincorporated organization or other entity.

(xiii) “Voting Stock” shall mean, with respect to a corporation, all securities of such
corporation of any class or series that are entitled to vote generally in the election of directors
of such corporation (excluding any class or series that would be entitled so to vote by reason of
the occurrence of any contingency, so long as such contingency has not occurred).

 

13

 

Syntroleum — Employment Agreement

CONFIDENTIAL

14. Severance shall not exceed Section 280G of the Internal Revenue Code. Not
withstanding the terms and conditions of Sections 12 or 13, the amount of severance compensation
shall in no event be greater than the amount which would be deductible by the Company under Section
280G of the Internal Revenue Code of 1986, as amended (the “Code”), after taking into consideration
all payments to Employee covered by Code Section 280G which Employee receives or is deemed to
receive (i) under this Agreement; (ii) under the Company’s 2005 Stock Option and
Incentive Plan, as amended, by reason of the acceleration of the right to exercise any options
(including any related stock appreciation rights) granted thereunder or the acceleration of the
vesting of any restricted stock awards granted thereunder; or (iii) under any new plan or
arrangement implemented by the Company or any party to a transaction which constitutes a Change of
Control after the date of this Agreement which would otherwise be considered a “parachute payment”
under Section 280G. In the event such payments exceed the amount which would be deductible by the
Company or other payor under Code Section 280G, the timing of such payments shall be extended or
otherwise modified or reduced such that such payments shall be deductible by the Company or other
payor under Code Section 280G and in a manner which, to the extent possible, provides Employee the
full benefit of such payments as originally agreed to.

15. Resignation Upon Termination. In the event of termination of this Agreement other
than for death, Employee agrees to resign from all positions held in the Company, including without
limitation any position as a director, officer, agent, trustee or consultant of the Company or any
affiliate of the Company.

16. Obligations Unconditional. The obligations of the parties under this Agreement
are unconditional and do not depend upon the performance of any agreements, duties, obligations, or
terms outside this Agreement.

17. Waiver. A party’s failure to insist on compliance or enforcement of any provision
of this Agreement shall not affect the validity or enforceability or constitute a waiver of future
enforcement of that provision or of any other provision of this Agreement by that party or any
other party.

18. Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE
WITH THE LAWS OF THE STATE OF OKLAHOMA, UNITED STATES OF AMERICA, WITHOUT REGARD TO CONFLICT OF LAW
PROVISIONS THEREOF.

19. Severability. If for any reason any paragraph, term or provision of this
Agreement is held to be invalid or unenforceable for any reason, such invalidity or
unenforceability shall not affect any other provision hereof, and this Agreement shall be construed
and enforced as if such provision had not been included herein and all other valid provisions
herein shall remain in full force and effect. If for any reason the restrictions and covenants
contained herein are held to cover a geographical area or be for a length of time which is
unreasonable or unenforceable, or in any other way are construed to be too broad or to any extent
invalid, then to the extent the same are or would be valid or enforceable under applicable law, any
court of competent jurisdiction shall construe and interpret or reform this Agreement to provide
for a covenant having the maximum area, time or other provisions (not greater than those contained
herein) as shall be valid and enforceable under such applicable law.

 

14

 

\

Syntroleum — Employment Agreement

CONFIDENTIAL

20. Jurisdiction. The Company and Employee intend to and hereby confer jurisdiction
to enforce the provisions of this Agreement and any restrictive covenants contained herein upon the
courts of any jurisdiction within the geographical scope of such covenants. If the courts of any
one or more of such jurisdictions hold the provisions of this Agreement or any of the restrictive
covenants contained herein unenforceable by reason of the breadth of such scope or otherwise, it is
the intention of the Company and Employee that such determination not bar or in any way affect the
Company’s right to the relief provided herein in the courts of any other jurisdiction within the
geographical scope of such covenants, as to breaches of such covenants, such covenants as they
relate to each jurisdiction being, for this purpose, severable into diverse and independent
covenants.

21. Notice. Any and all notices required or permitted herein shall be deemed
delivered if delivered personally or if mailed by registered or certified mail to the Company at
its principal place of business and to Employee at the address hereinafter set forth following
Employee’s signature, or at such other address or addresses as either party may hereafter designate
in writing to the other.

22. Amendments. This Agreement may be amended at any time by mutual consent of the
parties hereto, with any such amendment to be invalid unless in writing, signed by the Company and
Employee.

23. Burden and Benefit. This Agreement, together with any amendments hereto, shall be
binding upon and shall inure to the benefit of the parties hereto and their respective successors,
assigns, heirs and personal representatives. The Company may, in its sole discretion, assign this
Agreement or its rights hereunder to any parent, affiliate, shareholder, or successor of the
Company, or to any person or entity which purchases substantially all of the assets of the Company.
Employee may not transfer or assign this Agreement or any of Employee’s rights or obligations
under this Agreement.

24. References to Gender and Number Terms. In construing this Agreement, feminine or
number pronouns shall be substituted for those masculine in form and vice versa, and plural terms
shall be substituted for singular and singular for plural in any place which the context so
requires.

25. Headings. The various headings in this Agreement are inserted for convenience
only and are not part of the Agreement.

26. Entire Agreement. This Agreement contains the entire understanding and agreement
between the parties relating to the subject matter hereof.

27. Compliance With Section 409A. Notwithstanding anything to the contrary herein, if
any of the benefits payable pursuant to this Agreement shall be deemed to constitute nonqualified
deferred compensation, within the meaning of Section 409A of the Internal Revenue Code, then the
payment of such benefits shall be delayed until the earliest date on which such benefits can be
paid without subjecting the Employee to the payment of any interest or tax penalty which may be
imposed under Section 409A of the Internal Revenue Code, but in no event later than six months and
five days after the Employee’s separation from service, within the meaning of Section 409A.

 

15

 

Syntroleum — Employment Agreement

CONFIDENTIAL

28. Disputes. Any dispute arising out of or in connection with this Agreement,
including any question regarding its existence, validity or termination, shall be addressed in the
following order:

	 	(a)	 	Negotiation. The Company will designate a senior member of management to
represent it during the negotiations. Company’s designated negotiator and Employee
shall arrange a meeting, at a mutually convenient time by phone or in person, to
discuss the issues and negotiate for a resolution of the dispute. The period of
negotiation shall extend no longer than thirty (30) days from the first meeting of the
negotiators.

	 	(b)	 	Mediation. If the Company and Employee have failed to resolve the dispute by
negotiation, the Company and Employee shall submit to mediation prior to seeking
resolution by binding arbitration. The Company and Employee will cooperate with one
another in recommending a mediator from the American Arbitration Association panel of
neutrals, who shall be requested to promptly scheduling the mediation proceedings. The
Company and Employee covenant that they will participate in the mediation in good
faith, and that they will each bear its own costs. All offers, promises, conduct and
statements, whether oral or written, made in the course of the mediation by any of the
parties, their agents, employees, experts and attorneys, and by the mediator, are
expected to be treated as confidential, privileged and inadmissible for any purpose,
including impeachment, in any arbitration or other proceeding involving the parties,
provided that evidence that is otherwise admissible or discoverable shall not be
rendered inadmissible or non-discoverable as a result of its use in the mediation. If
the dispute is not resolved within thirty (30) days from the date of the submission of
the dispute to mediation (or such later date as the parties may mutually agree in
writing), the administration of the arbitration shall proceed forthwith. The mediation
may continue, if the Company and Employee so agree, after the appointment of the
arbitrators. Unless otherwise agreed by the Company and Employee, the mediator shall
be disqualified from serving as arbitrator in the case. The pendency of a mediation
shall not preclude a party from seeking provisional remedies, such as a temporary or
permanent injunction or restraining order to prevent a continuing harm to a party, in
aid of the arbitration from a court of appropriate jurisdiction, and the Company and
Employee agree not to defend against any application for provisional relief on the
ground that a mediation is pending.

 

16

 

Syntroleum — Employment Agreement

CONFIDENTIAL

	 	(c)	 	Arbitration. Within five (5) business days of the conclusion of the mediation,
any dispute, claim or controversy arising out of or relating to this Agreement or the
breach, termination, enforcement, interpretation or validity thereof, including the
determination of the scope or applicability of this Agreement to arbitrate, shall be
determined by binding arbitration in Tulsa, Oklahoma, before three (3)
arbitrator(s). The arbitration shall be administered by the American Arbitration
Association pursuant to its Commercial Rules for Arbitration. If the dispute is not
resolved within thirty (30) days from the date of the submission of the dispute to
arbitration (or such later date as the Company and Employee may mutually agree in
writing), the Company or Employee may proceed to litigation in accordance with this
Agreement. Judgment on the award may be entered in any court having jurisdiction
over a party. This clause shall not preclude the Company or Employee from seeking
provisional remedies in aid of arbitration, such as a temporary or permanent
injunction or restraining order to prevent a continuing harm to a party, from a
court of appropriate jurisdiction. The Company and Employee covenant that they will
participate in the arbitration in good faith, and that they will each bear its own
costs. The provisions of this section may be enforced by any Court of competent
jurisdiction, and the party seeking enforcement shall be entitled to an award of all
costs, fees and expenses, including attorneys’ fees, to be paid by the party against
whom enforcement is ordered.

	 
	 	(d)	 	Litigation. In the event that the dispute resolution procedure set forth in
Section 28(a), (b) or (c) are held unenforceable by a court of competent jurisdiction,
the Company and Employee agree to litigate any dispute, claim or controversy arising
out of or relating to this Agreement or the breach, termination, enforcement,
interpretation or validity thereof, before the State courts sitting in Tulsa County, in
Tulsa, Oklahoma for a non-jury (bench) trial, and the prevailing party shall be awarded
its costs of litigation. If the case or controversy meets the requirements for removal
to the Federal Court system, the Company and Employee agree that removal to Federal
Court shall only be to the U.S. District Court for the Northeastern District of the
State of Oklahoma, subject to a non-jury (bench) trial. In the event a party elects to
utilize the dispute resolution mechanism of Litigation, without first undertaking good
faith participation in Negotiation, Mediation, or Arbitration, the party making the
election of Litigation shall be obligated for all costs (internal and external) of the
other party.

 

17

 

Syntroleum — Employment Agreement

CONFIDENTIAL

IN WITNESS WHEREOF, the Company and Employee have duly executed this Agreement as of the date and
year first above written.

	 	 	 	 	 
	 	COMPANY:

SYNTROLEUM CORPORATION

 	 
	 	By:  	/s/ Edward G. Roth
 	 
	 	 	Edward G. Roth 	 
	 	 	President and Chief Operating Officer

Syntroleum Corporation.

4322 South 49th West Avenue

Tulsa, Oklahoma  74107

EMPLOYEE: 	 
	 
	 	By:  	                       /s/ Karen L. Gallagher
 	 
	 	 	Name:  	Karen L. Gallagher 	 
	 	 	 	 

 

18

 

	 	 	 	 	 

Syntroleum — Employment Agreement

CONFIDENTIAL

Exhibit A

Initial Duties and Responsibilities

	•	 	Oversee the financial and accounting controls and processes to ensure timely financial
reporting that adheres to GAAP, SEC reporting and Sarbanes-Oxley compliance requirements;

	•	 	Evaluate existing accounting policies and procedures and establish new accounting
policies and procedures required to adhere to GAAP, SEC and Sarbanes Oxley compliance
requirements;

	•	 	Identify and implement accounting policies and procedures associated with the
development of managed technology and construction projects in the range of $100 to $250
million;

	•	 	Report financial results to the Board and executive management. Oversee monthly filings
and dissemination of accounting documents;

	•	 	Plan, organize, and direct the financial management control functions;

	•	 	Set forth desired objectives, develops procedures and proposes changes in existing
accounting and control methods;

	•	 	Direct the planning, organization and implementation of the overall procedures for
financial reporting, managerial reporting, cash management, risk management, Sarbanes-Oxley
compliance and audit compliance;

	•	 	Working with the Chairman of the Board, Prepare/Coordinate the development of all Board
related materials including all Board meetings, audit committee meetings, and the Annual
Meeting of Shareholders;

	•	 	Prepare all required SEC filings and sign such filings in the capacity of the Principal
Accounting Officer;

	•	 	Direct accounting activities for all corporate entities and ensure the accounts and
records required for all reporting (including income tax reporting) are maintained;

	•	 	Direct the information technology department;

	•	 	Direct the risk management function associated with various insurances including general
business insurance, D&O coverage, construction coverage, etc;

	•	 	Direct the operations of the human resources department;

	•	 	Perform such other duties as may be assigned by Employee’s supervisor, Executive
Committee, and/or Board of Directors

 

19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00132-of-00352.parquet"}]]